Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
AVNT Avient
- 36.120
- +0.650+1.83%
Close May 7 16:00 ET
- 36.890
- +0.770+2.13%
Pre 05:32 ET
3.31BMarket Cap33.44P/E (TTM)
36.450High35.440Low989.14KVolume35.460Open35.470Pre Close35.66MTurnover1.10%Turnover Ratio19.63P/E (Static)91.53MShares54.01352wk High1.44P/B3.25BFloat Cap27.86052wk Low1.06Dividend TTM89.86MShs Float56.505Historical High2.92%Div YieldTTM2.85%Amplitude1.019Historical Low36.051Avg Price1Lot Size
Avient Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -19.39%-51.1M | 27.38%256.8M | -20.65%122.6M | -0.97%71.1M | 4,336.00%105.9M | -92.79%-42.8M | -49.40%201.6M | -11.46%154.5M | -38.74%71.8M | -102.85%-2.5M |
| Net income from continuing operations | -140.04%-19.9M | 124.02%170.7M | 70.77%48.5M | 658.82%38.7M | 51.57%33.8M | 143.63%49.7M | -89.17%76.2M | -94.79%28.4M | 147.66%5.1M | -73.67%22.3M |
| Depreciation and amortization | 2.26%45.3M | -4.82%179.7M | 2.48%45.4M | -2.80%45.1M | -5.67%44.9M | -12.28%44.3M | 15.76%188.8M | -9.22%44.3M | 16.00%46.4M | 30.41%47.6M |
| Deferred tax | ---- | 61.17%-23.8M | ---- | ---- | ---- | ---- | -12,360.00%-61.3M | ---- | ---- | ---- |
| Other non cash items | --34M | ---34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -31.69%-184.5M | -157.66%-51.2M | -40.11%83.6M | -189.01%-16.2M | -21.25%21.5M | -45.48%-140.1M | 141.96%88.8M | 46.79%139.6M | -78.51%18.2M | 174.79%27.3M |
| -Change in receivables | -2.20%-83.7M | -139.38%-15.2M | 14.00%50.5M | -48.60%31.3M | 42.80%-15.1M | -103.73%-81.9M | 18.40%38.6M | -55.30%44.3M | -8.70%60.9M | -83.33%-26.4M |
| -Change in inventory | -65.04%-20.3M | -156.38%-13.7M | 111.54%16.5M | -216.00%-2.9M | -247.06%-15M | -423.68%-12.3M | 73.57%24.3M | -70.57%7.8M | -92.51%2.5M | 133.12%10.2M |
| -Change in payables and accrued expense | -75.38%-80.5M | 639.53%23.2M | -47.26%28.9M | 46.50%-17.6M | 454.60%57.8M | -363.64%-45.9M | 67.67%-4.3M | 196.48%54.8M | 40.18%-32.9M | -303.75%-16.3M |
| -Change in other working capital | ---- | -250.66%-45.5M | -137.61%-12.3M | -119.51%-27M | -30.77%41.4M | 4.80%-47.6M | 788.24%30.2M | 24.33%32.7M | -131.06%-12.3M | 8,442.86%59.8M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -19.39%-51.1M | 27.38%256.8M | -20.65%122.6M | -0.97%71.1M | 4,336.00%105.9M | -92.79%-42.8M | -49.40%201.6M | -11.46%154.5M | -38.74%71.8M | -102.85%-2.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 48.98%-12.5M | -28.03%-120.6M | -42.71%-41.1M | 6.72%-25M | -17.19%-30M | -88.46%-24.5M | 81.31%-94.2M | -103.26%-28.8M | 98.12%-26.8M | -147.06%-25.6M |
| Capital expenditure reported | 48.77%-12.5M | -2.09%-121.9M | 7.43%-41.1M | 14.09%-25M | -22.66%-31.4M | -20.20%-24.4M | -13.18%-119.4M | 11.90%-44.4M | -37.91%-29.1M | -23.67%-25.6M |
| Net PPE purchase and sale | --0 | -55.26%3.4M | --0 | --0 | --1.4M | --2M | 24.59%7.6M | --7.6M | --0 | --0 |
| Net business purchase and sale | ---- | --0 | --0 | --0 | --0 | --0 | 101.47%7.3M | --0 | --0 | --0 |
| Net other investing changes | ---- | -120.39%-2.1M | --0 | --0 | --0 | ---2.1M | -88.96%10.3M | --8M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 48.98%-12.5M | -28.03%-120.6M | -42.71%-41.1M | 6.72%-25M | -17.19%-30M | -88.46%-24.5M | 81.31%-94.2M | -103.26%-28.8M | 98.12%-26.8M | -147.06%-25.6M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -0.71%-28.3M | 40.06%-120.9M | -5.45%-27.1M | 69.46%-39M | -17.62%-26.7M | -9.77%-28.1M | -221.21%-201.7M | 97.36%-25.7M | -110.41%-127.7M | 49.10%-22.7M |
| Net issuance payments of debt | --0 | 89.70%-10.9M | 10.00%-1.8M | 95.53%-4.6M | -800.00%-1.8M | -237.50%-2.7M | -130.83%-105.8M | 99.79%-2M | -107.92%-102.8M | 90.00%-200K |
| Net common stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash dividends paid | -5.11%-24.7M | -4.21%-94M | -3.98%-23.5M | -3.98%-23.5M | -4.44%-23.5M | -4.44%-23.5M | -3.92%-90.2M | -4.63%-22.6M | -4.15%-22.6M | -3.21%-22.5M |
| Net other financing activities | -89.47%-3.6M | -180.70%-16M | -63.64%-1.8M | -373.91%-10.9M | ---1.4M | 17.39%-1.9M | 89.37%-5.7M | -1,000.00%-1.1M | 95.34%-2.3M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -0.71%-28.3M | 40.06%-120.9M | -5.45%-27.1M | 69.46%-39M | -17.62%-26.7M | -9.77%-28.1M | -221.21%-201.7M | 97.36%-25.7M | -110.41%-127.7M | 49.10%-22.7M |
| Net cash flow | ||||||||||
| Beginning cash position | -0.24%544.5M | -14.87%545.8M | 15.04%505.7M | -7.43%489.4M | -23.75%444.3M | -14.87%545.8M | 6.64%641.1M | -19.25%439.6M | -18.04%528.7M | 3.57%582.7M |
| Current changes in cash | 3.67%-91.9M | 116.22%15.3M | -45.60%54.4M | 108.59%7.1M | 196.85%49.2M | -56.91%-95.4M | -255.10%-94.3M | 15.34%100M | 3.05%-82.7M | -152.05%-50.8M |
| Effect of exchange rate changes | 155.74%3.4M | -1,560.00%-16.6M | -351.61%-15.6M | 243.75%9.2M | -28.13%-4.1M | -354.17%-6.1M | 95.22%-1M | -38.00%6.2M | 58.44%-6.4M | 78.81%-3.2M |
| End cash Position | 2.63%456M | -0.24%544.5M | -0.24%544.5M | 15.04%505.7M | -7.43%489.4M | -23.75%444.3M | -14.87%545.8M | -14.87%545.8M | -19.25%439.6M | -18.04%528.7M |
| Free cash flow | 5.36%-63.6M | 64.11%134.9M | -25.98%81.5M | 7.96%46.1M | 365.12%74.5M | -58.12%-67.2M | -71.94%82.2M | -11.28%110.1M | -55.57%42.7M | -141.88%-28.1M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025